Micro Flashcards

1
Q

Decrease abx peak concentration

A

Reduced gut absorption
Increased Vd
Reduced penetration to site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Increase Abx peak concentration

A

Reduced protein binding

Reduced clearance mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Increase Abx t 1/2

A

Decreased renal or hepatic clearance

Decreased overall metabolism eg hypothermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Decrease Abx t1/2

A

RRT
INCREASED hepatic clearance
Increased glomerular filtration
Increased drug metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ways that critical illness can change pharmacokinetics and dynamics of Abx

A

Enhanced organ toxicity due to poor clearance and increased risk of damage to organs directly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does shock affect pharmacokinetics and dynamics of Abx

A

Increased Vd
Decreased bioavailability of basic drugs (due to increase in alpha 1 glycoproteins)
Increased penetration of formerly impenetratable tissue eg meningitis
Impaired hepatic metabolism due to inhibited cyp 450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
In renal failure you would..... For
Beta lactams
Carbapebems
Aminoglycosides
Fluriquinolones
Glycopeptides
A

BL - can be dose of interval adjusted
Carb - as above
Amino - same dose, interval adjust, check levels
Fluor - same dose, interval adjust, check QT
Glycopeptides - same dose, interval adjust, check levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Interval adjusting is most relevant for;

A

Concentration dependent abx which have toxicity with high levels
Examples - amino glycosides and Glycopeptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why do you dose adjust Abx

A

Relevant for time dependent abX that have toxicity associated with high concentration peaks
Eg fluroquinolones

Important to be above MIC for as long as possible - only need to load and then give small frequent doses to remain above MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Abx that rely on renal clearance

A
Beta lactams, cephalosporins and car spends
Amino glycosides
Fluconazole
Aciclovir
Vanc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Abx that do not need adjustment with renal failure

A
Linezolid
Clindamycin
Amphoteracin
Azitgromyxib
Ceftriaxome
Voriconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

General principles of abx dose adjusting in CRRT

A

Abx with time dependent killing - if rapidly cleared by CRRT need to give more frequently

Abx with concentration dependent killing - if cleared rapidly dose should be increased

If RRT is intermittent eg SLED should give at the end of each session

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs with large Vd, which do not rely on renal clearance

Eg - don’t need changes with RRT

A
Ceftriaxone
Moxifloxacin
Clindamycin
Linezolid
Voriconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs that have large Vd and rely on renal clearance - need to have increased dosing interval as the filter can’t act the same way as the kidney with active pumps

A

Levofloxacin
Ciprofloxacin
Colostin
Amphiteracin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs with small Vd that do rely on renal clearance - doe shouldn’t be adjusted with RRT as the filter can act as kidney in terms of glomerular filtration action

A
Beta lactams
Carbapenems
Amino glycosides
Glycopeptides
Fluconazole

MAY need to increase dose as filter may be more efficient esp fluconazole which must be increased at high filter rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Time dependent Abx

A
Beta lactams
Carbapenems
Monobactams
Linezolid
Clindamycin
Macrolides

Abx that kill bacteria most effectively when the bacteria are about to divide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Concentration dependent killing abx

A

Amino glycosides
Metronidazole
Daptomycin

Drugs that affect bacterial metabolism or protein synthesis; higher concentration means more enzyme molecules are inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Time and concentration dependent killing

A
Fluroquinolones
Azithromycin
Tetracyclines
Vanc
Tigecycline

Drugs that inhibit DNA synthesis or other components of cellular division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why are Abx not working

A

Wrong dose
Delayed dose
Inadequate source control
Inadequate blood levels
Inadequate penetration
Anti microbial neutralisation or antagonism
Superinfection or unsuspected secondary infection
Non bacterial infection
Non infectious source of illness
Eagle effect - paradoxical loss of effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Factors that influence Abx choice

A

Disease factors - travel hx, occupation, ivdu, reliability of cultures
Host factors - age, allergies, pregnancy
Organism factors - source control, susectibility,
Drug factors - cost, toxicity, drug synergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MIC definition

A

The lowest concentration of an antimicrobial that will inhibit visible growth of an organism after overnight incubation

Lower MIC = more effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Drugs with post antibiotic effect

A
Those with concentration dependent kill characteristics;
Amino glycosides
Clindamycin
Macro life's
Tetracyclines
Rifampicin
Dalfopristin

Is when effects are seen long after concentration below MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Drugs with no post Abx effect

A

Beta lactams
Cephalosporins
Monobactams

These would benefit from continuous infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Polyenes

A

Antifungals - Amphiteracin and nystatin

They weaken cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Amphiteracin

A

Active against fungi and yeast
Large Vd
No reliance on renal clearance
Toxicity - nephrotoxic, hypokalaemia, fever Ags chills, RTA, hypochromic normocytic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Azoles

A

Antifungals
Fluconazole, Voriconazole
Prevent synthesis of ergosterol
Early generations are only active against candida albicans and, most non albicans and are resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Fluconazole

A
Candida albicans
Other candida resistant
Active against cryptococcus
No activity against aspergillus
Penetrates into CSF
Small Vd
Relies on renal clearance, readily cleared by dialysis
Toxicity - LFTS, alopecia, drug interactions (inhibits CYP 450)

Prophylaxis - use does not reduce mortality IV surgical pts
May reduce mortality if given in septic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Voriconazole

A

Covers all candida, cryptococcus, aspergillus
Highly protein bound
Vd massive
Not renally cleared, not dialysable
Inhibits CYP 450
Toxicity - long Qt, hallucinations, psychosis, drug interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Echinocandins

A

Anti fungal eg caspofungin
Inhibit cell wall synthesis by blocking synthesis of glycine 1,3 beta glucose synthase
Very active against candida, useless for cryptococcus, not very helpful for aspergillus
Highly protein bound
But dependent on renal excretion, not dialysable
Minimal toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Toxicities of linezolid

A
Thrombocytopaenia 
Anaemia
Neuropathy
Lactic acidosis
Serotonin syndrome

All due to mitochondrial toxin activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Teicoplanin toxicity

A

Renal or liver dysfunction
Thrombocytopaenia
Anaemia

32
Q

Tigecycline toxicities/se’s

A

N&V,

Teratogenic

33
Q

Daptpmycin toxicity

A

Myopathy

34
Q

Indicators of severity in CAP

A
Minor-
RR >30
PF <250
confusion
raised urea
low WCC
low plat
low temp
low BP

Major -

  • invasive ventilation
  • need for vasopressors
35
Q

Slow reponders to treatment in pneumonia

A
aspergillus
Q fever
TB
nocardia
leptospirosis
melioidosis
36
Q

Risks for VRE

A
long admission
renal impariment
enteral tube feeding
proximity to VRE patients
elderly
long term IV access
inter hospital transfer
low staff:patient ratio
haematological malignancy
multiple courses of Abx
37
Q

Risks for C diff

A
Abx exposure - cipro ,clinda, beta lactams, cephalo
immunosuppresant drugs, cytotoxic drugs
age >65
PPI
renal impairment
long admission
38
Q

treatment of VRE

A

linezolid
teicoplanin (if Van B)
daptomycin
tigecycline

39
Q

consequences of VRE

A

systemic infection - determined by site of infection

transfer of resistance to staph aureus

40
Q

qSOFA pros and cons

A

Easy
Has good predictive validity (AUROC 0.81)

BUT -

  • validated retrospectively
  • “new onset” vs old changes??
  • not proven to be valid in a range of clinical settings
41
Q

non-albicans candidaemia is associated with;

A
Repeated abdominal surgeries
Exposure to broad-spectrum antibiotics
Exposure to fluconazole
Diabetes
CVC insertion
TPN use
Malignancy
Renal failure
42
Q

Complications of candidaemia

A
Candida endopthalimitis/retinitis
Candia endocarditis
Hepatosplenic abscesses
Pulmonary cavitating lesions
CNS involvement (meningitis or abscesses)
Candida arthritis
43
Q

Lab confirmation of malaria

A

Thick (parasite load) and thin (parasite species) blood smears

Rapid diagnostic tests utilising malarial antigens (dependents on specific test)

44
Q

firstline drugs for malaria

A
Cinchona alkaloids (quinine and quinidine)
Artemisinin derivatives (artesunate, artemether).

Also -
tetracyclines (eg doxycycline), napthoquinones (eg. atovaquone) and lincosamides (eg. clindamycin).

45
Q

Acute complications of malaria

A

Cerebral Involvement with or without convulsions

Respiratory Failure - acute respiratory distress syndrome (ARDS)

Circulatory collapse

GI - 
• Renal failure, hemoglobinuria ("black water fever")
• Hepatic failure
• Splenic Rupture
 - hepatosplenomegaly

Haematological
• Disseminated intravascular coagulation
• Severe anemia secondary to Haemaolysis
• Thrombocytopenia

Metabolic
• Hypoglycemia
• Severe Acidosis
• Hyponatraemia
-high fever and rhabdo due to rigors
46
Q

Steps to take if approaching Ix of increase in infection rate (eg MRSA)

A

Investigate the validity of the reported colonisation rate
Investigate the demographics of the colonised patients
Investigate the origin of the patients (which ward are they coming from?)
Revisit the current infection control policy: is it time to rewrite it?
Get expert opinions from infectious diseases and infection control specialists
Form a multidisciplinary review panel (ICU specilists, ID physicians, NUMS and RNs)
Review the current literature on infection control
Rewrite infection control policy
Educate the staff regarding the new policy
Implement rigorous standards regarding hand washing and bed space cleaning
Monitor the effects of the implemented policies

47
Q

differential causes of puprura fulminans

A

DIC from any cause
Sepsis due to the following organisms:
- S.pneumoniae - but mainly in asplenic patients for some reason
- S.aureus
- H.influenzae
- N.meningitides
Endocarditis of any bacterial aetiology
MAHA (microangiopathic haemolytic anaemia)
TTP (thrombotic thrombocytopenic purpura)
Varicella infection
Rickettsial infection
Plasmodium falciparum malaria
Vasopressor excess
Warfarin-induced skin necrosis
Congenital Protein C anticoagulant pathway defect
Post-infectious purpura fulminans (due to autoimmune destruction of proteins C or S)

48
Q

Risk factors for CMV in the immunocompetent host

A

Critical illness in general seems to be a risk factor.

Risk factors for reactivation:

  • Trauma
  • Burns
  • Severe critical illness (high APACHE score, over 27)
  • Blood transfusion
  • Mechanical ventilation
  • Severe sepsis
  • Prolonged ICU stay
  • Pregnancy
49
Q

diagnosis of CMV

A

Positive CMV antibodies (IgM) - sensitive for recent or acute infection

Qualitative PCR - very sensitive for the presence of CMV, but they do not distingusih between active and latent infection.

Quantitative PCR - ideal test, as it provides a quantitative assessment of viral load, and allows the monitoring of therapy.

50
Q

complications of CMV

A
Colitis
Hepatitis
Encephalitis
Guillain-Barre syndrome
Pneumonitis (rare)
Pericarditis and myocarditis
Uveitis and retinitis
51
Q

Complications of CMV in the Immunocompromised (transplant) host

A

Chronic allograft nephropathy (renal transplant)
Hepatic artery thrombosis (liver transplant)
Accelerated Hep C recurrence (liver transplant)
Bronchiolitis obliterans (lung transplant)
New onset NIDDM
Post-transplant lymphoproliferative disease

52
Q

Management of CMV infection

A

Ganciclovir - initially
valganciclovir - when infection under control

Resistant strains - foscarnet and cidofovir

53
Q

Virology of CMV

A

May be present in breast milk, saliva, feces, and urine.
Not readily spread by casual contact. Requires prolonged or intimate exposure.
Once infected, it is carried for life.
Reactivation occurs when T-cell immunity is impaired.
In organ transplant recipients, the transplanted organ is often the reservoir.

54
Q

“Cytomegalovirus” is so called because… (interesting facts - because i dont have enough to learn)

A

the affected cells are two to four times the size of unaffected cells.
These cells typically have large “owl’s eye” inclusions

55
Q

treatment options from MRSA aside from vanc

A

Tigecycline
Linezolid (particularly for MRSA pneumonia, where vancomycin penetrates poorly)
Quinupristin/dalfopristin
Daptomycin
Fosfomycin (usually to enhance the effects of other drugs)
Rifampicin/fusidic acid (particularly for deep bone and joint infections)
Telavancin, dalbavancin and oritavancin
Ceftobiprole and ceftaroline
Iclaprim
Trimethoprim/sulfamethoxazole
Moxifloxacin

56
Q

Non infectious causes of fever

A

Vascular

  • Cerebral infarction/hemorrhage
  • Myocardial infarction
  • Ischemic bowel
  • Subarachnoid hemorrhage
  • Fat emboli
  • Deep venous thrombosis/PE
  • Phlebitis/thrombophlebitis

Neoplastic

  • Lymphoma-associated fever
  • Renal cell carcinoma
  • Tumour lysis syndrome

Drug-induced

  • Alcohol/drug withdrawal
  • Drug fever

Idiopathic inflammatory

  • Postoperative fever (48 h postoperative)
  • Acalculous cholecystitis
  • Pancreatitis
  • Aspiration pneumonitis
  • ARDS
  • Gout/pseudogout
  • IV contrast reaction
  • GI bleed

Autoimmune

  • Posttransfusion fever
  • Transplant rejection
  • Vasculitis
  • Haemolytic anaemia

Traumatic/environmental

  • Haematoma degradation
  • Decubitus ulcers
  • Heat stroke

Endocrine

  • Adrenal insufficiency
  • Thyrotoxicosis
  • Thyroiditis (Hashimoto)
  • Ovulation/pregnancy
57
Q

Biochemical markers of sepsis include:

A
CRP
Procalcitonin
LPS-binding protein
sTREM-1
Presepsin (sCD14-st)
HMGB-1
58
Q

mechanisms that lead to vasodilation in sepsis

A

Nitric oxide synthase induction by cytokines and endotoxin

Direct vascular smooth muscle response to acidosis and hypoxia

Inflammatory mediators produced by activated leucocytes

Vasodilatory mediators (eg. histamine bradykinin and serotonin) produced by leukocytes and platelets

Relative vasopressin deficiency

Relative adrenal insufficiency, resulting in peripheral catecholamine insensitivity

Acidosis, resulting in peripheral catecholamine insensitivity

59
Q

Opportunistic infections and treatment

A

CMV - valganciclovir
Aspergillus - voriconizole or amphoteracin
Pneumocystis - bactrim
Nocardia - suphonamides

60
Q

risk factors for Varicella pneumonia:

A
Immunocompromised
Pregnancy
Chronic lung disease
Adults (greater risk compared to children)
Smoking
Number of spots - over 100
61
Q

Causes of seizures in meningitis

A

cerebritis
cerebral venous sinus thrombus
increased intracranial pressure
abscess

62
Q

causes of functional asplenia

A

sickle cell disease
alcoholic liver disease
coeliac disease

63
Q

Risk factors for pneumococcal bacteraemia

A
Extreme of age <2 or >65
Chronic lung disease
Asplenia both functional and anatomic
Immunosuppression 
Transplant patients 
CSF leaks
Cochlear implants
64
Q

Risk factors for acalculous cholecystitis

A
Trauma with massive transfusion
Any recent surgery
Burns
Sepsis
TPN
Prolonged fasting
Critical illness in general
65
Q

Radiological and Ultrasonographic Features of

Acalculous Cholecystitis

A
Thickened gall bladder wall (over 3.5-4mm)
Pericholecystic fluid
Intramural gas
Echogenic or hyperdense bile sludge
Sloughed mucosa
Gall bladder distension
66
Q

Pathogens commonly responsible for acalculous cholecystitis

A
E.coli
Klebsiella
Proteus
Enterococcus
Bacteroides
67
Q

treatment of prosthetic valve IE

A

vancomycin, gentamicin and rifampicin

68
Q

stereotypical criteria for toxic shock syndrome

A

High fever (> 38.9°)
Hypotension and shock
Rash consistent with diffuse macular erythroderma
Desquamation, particularly of the palms and soles

There are also non-diagnostic associated features:

Rapid onset: ~ 2 days
Staphylococcus may grow in the blood (but blood cultures otherwise negative)
Multisystem organ involvement

69
Q

Pathogenesis of toxic shock syndrome

A

Some staphylococci produce a characteristic protein (the Toxic Shock Syndrome Toxin, or TSST-1, 2 and 3).

TSST activates T-cells directly, acting as a “superantigen” -> Massive inflammatory cytokine release
Endothelial dysfunction and vasodilatory shock ensues, which is out of proportion to the severity of the initiating infection.

70
Q

Risk factors for toxic shock syndrome

A
Being female
Use of tampons
Mastitis
Sinusitis
Osteomyelitis
Burns
Compromised immune system (eg. HIV)
71
Q

Adjuncts to management that involve toxin/endotoxin

A
Clindamycin as an adjunct (prevents the synthesis of TSST)
Intravenous immunoglobulin (to bind circulating TSST)
72
Q

tests to do with meningitis if gram stain negative

A
Herpes Simplex PCR
Mycobacterium Tuberculosis PCR 
Mycobacterial Stain and Cultures
India Ink Stain, Cryptococcal Ag 
Fungal cultures
Bacterial PCR
73
Q

ways to decrease risk of CVC infection:

A

Intelligence use of CVCs (i.e. does the patient even need one?)
Subclavian lines.
Minimum number of lumens.
Use of dedicated lumens for lipid infusions.
Immunosuppressed patients or those with burns should have antibiotic-coated lines.
For insertion, use aseptic technique and maximal barrier precautions.
0.5% chlorhexidine in 70% alcohol is the preferred cleaning agent.
Handle ends of administration sets with gauze soaked in chlorhexidine).
Review the line daily.
Remove the line as soon as possible.
Change lines early - ideally, every 7 days.
Sterile, transparent semipermeable dressings
Change dressings regularly (every 7 days for standard dressings)

74
Q

Alternative pathogens causing pseudomembranous colitis

A
Strongyloides stercoralis
Staphylococcus aureus
Clostridium perfringens
Yersinia
CMV
Entamoeba
Listeria

All the enterohaemorrhagic diarrhoea organisms:

  • Salmonella
  • Shigella
  • Campylobacter
  • E.coli
75
Q

treatment for moderate - severe pneumonia

A

beta lactam and macolide (eg azithromycin 500mgod)

Continue for 7-10 days

NB - mild/mod infection; ceph and azithro, 5 days

76
Q

Aetiology of nosocomial infection in ICU:

A

Pneumonia: VAP or HAP
Central line associated bacteraemia
UTI due to indwelling catheters
Sinusitis due to nasogastric tubes
Acalculous cholecystitis due to parenteral nutrition
Pressure area infections
Meningitis or ventriculitis due to EVD infection
C.difficile infections due to broad-spectrum antibiotic use
Surgical site infections

77
Q

Causes of raised lactate in sepsis

A

endogenous catecholamine release and used of adrenaline
Circulatory faliure due to hypoxia and hypotension
Cytopathic hypoxia - widespread microvascular shunting and mitochondrial failure
inhibition of pyruvate dehydrogenase by endotoxin
Coexistent liver disease